GLP-1 medications can significantly delay gastric emptying
New GLP-1 drugs have emerged, including Eli Lillys tirzepatide (Mounjaro for diabetes, Zepbound for obesity), which activates both GLP-1 and GIP receptors and has produced even greater weight loss than semaglutide
Cigna : Select plans offer coverage, especially for obesity and related health conditions
The team, led by graduate fellow Nicole DelGaudio and postdoctoral fellow Hsi-wen Yeh, then analyzed the metabolites in these organelles to reveal how mitochondrial metabolites shift when cancer cells colonize new sites
Como se detalla extensamente en el artculo Fibromialgia: claves clnicas y estrategias multidisciplinares para una atencin integral , la enfermedad se interpreta hoy desde un modelo multifactorial, donde interactan vulnerabilidades genticas, factores psicosociales, desregulaciones neuroendocrinas y alteraciones biolgicas persistentes